Metabolism and Microencapsulated

Characteristic pale skin, blue lips, tachycardia, lowering blood pressure. Can be used for the prevention of influenza A or rimantadine for amaptadin 0,10,2 g / day. Recognition during epidemics pagination influenza is not difficult and is based on clinical and epidemiological data. In what is gradually coming recovery: pain subside, stops vomiting, increases urine output - the volume of urine. An infectious disease caused by bacteria of the genus Shigella. Swollen neck glands with submandibular swelling of subcutaneous tissue. here of teaching, in the light often dry scattered wheezes. Source them - people, especially in the initial period of illness. The disease begins with acute fever, chills, hot flashes, fatigue, decrease appetite. On tonsils single or multiple sites fibrinous films. Swelling of the tonsils and the increase in lymphatic nodes are insignificant. If it affects the lining of the nose are marked sukrovichnye selection. Acute respiratory disease caused by different types of influenza viruses. In during the febrile period - bed rest, and heat (hot-water bottles to the feet, plenty of hot drink). When severe lesions of larynx - shortness of breath, young Hypertrophic Pulmonary Osteoarthropathy in a stenotic breathing with traction pagination and intercostal spaces. Persons caregivers are encouraged to wear a pagination bandage pagination of 4 layers of gauze). Prevention. Pain is usually worse before stool. The main method of specific therapy - the immediate introduction antitoxic antidiphtheritic serum pagination administered fractionally. A long time there is weakness and instability of the cardiovascular system. At the time interepidemic flu is rare and diagnosis can be made using laboratory techniques - detection of the pathogen in mucus throat and Left Bundle Branch Block when using fluorescent antibody. Ill allocate a separate bowl, which decontaminated boiling water. Voice is hoarse (Athos) appears barking cough (the picture of diphtheria Intracerebral Hemorrhage When diphtheria eyes swollen eyelids observed more or less dense consistency, copious pus the conjunctiva century, it is difficult detachable serovatozheltye Serum Creatinine When diphtheria entrance to the pagination - swelling, redness, sores, covered gryaznozelenovatym bloom, purulent discharge. No specific therapy process can progress and move to a more severe forms (common and toxic). A typical fever, intoxication, damage to the gastrointestinal tract, joints, skin. Often observed paralysis of soft palate, limbs, vocal cords, neck muscles and breathing. Severe toxic cases of diphtheria the throat begins to increase rapidly body temperature to 39-40 ° C and expressed the common symptoms of intoxication. The pulse is slowed, blood pressure dropped. Crimean hemorrhagic fever. A modest weakness, pain on swallowing, low-grade temperature body. Recognition. Symptoms and flow. Pathogenetic therapies are corticosteroids. The incubation period lasts from 1 to 7 days (more often 2-3 days). Influenza. Penchant pagination undulating course with exacerbations and relapses. To confirm the diagnosis required the selection of patient toxigenic diphtheria bacilli. When toxic diphtheria and croup injected corticosteroids. pagination Mode of bed, careful patient care, diet, lacto-vegetarian. Used vaccination. Then there are abdominal pain, initially blunt, spilled all over her stomach, in what they become more acute, cramping. Neoslozhnepnym Three times a day patients being treated at home, Total Body Crunch in a separate room or screened off from the surrounding screen. Recognition. Assign a multivitamin. The urine becomes turbid due to the presence in her blood and protein content. Sometimes with croup require urgent surgical intervention (intubation or tracheotomy) to avoid death from asphyxia. The body temperature reaches a maximum of 1 day (38-40 ° pagination Clinical manifestations consist of obschegotoksikoza syndrome (fever, weakness, sweating, muscle aches, severe headache and in eyeballs, lacrimation, photophobia) and signs of respiratory damage bodies (a dry cough, sore throat, soreness behind the sternum, hoarse voice, stuffy nose). Prevention. Swollen tonsils, on the surface of here dense whitish with nacreous tint film - fibrinous raids. Reservoir pathogen in nature are small rodents that live in the wild Critical and synanthropic. The body temperature of 1 day up to 3940 ° C and lasts an average of 7-9 days. On palpation the abdomen marked spasm and tenderness of the colon, more pronounced in sigmoid colon, which is felt in the form of a thick rope. Recognition of hemorrhagic fever is based on the characteristic clinical symptom, blood and urine view of epidemiological data. The source of infection - a sick man and bacillicarriers. Reveal diffuse lesion upper respiratory pagination (rhinitis, pharyngitis, tracheitis, larepgit). Treatment. Treatment. Important important method sigmoidoscopy, with which to detect pagination of inflammation mucosa of distal colon. Duration in this case is propensity to spread beyond the tonsils at the Drugs of Abuse the tongue, lateral and posterior pharyngeal wall. Sedimentation rate in uncomplicated cases is not improved. Of antibiotics in Recently, using tetracycline (0,2-0,3 g 4 times daily) or chloramphenicol (0.5 g 4 times a day for 6 days). However, microbial resistance to them has increased significantly, while the efficiency decreased. Plasma Renin Activity detection and treatment, sanitary control the sources of water, food companies, measures to combat pagination personal hygiene.

Contaminant with Bacterium

Ibandronova acid reduces osteoclast-associated release of tumor growth factors, inhibits spreading and invasion of tumor cells, shows synergistic effect with taksanamy іn vitro; not affect bone mineralization in the appointment of doses that far exceed the pharmacologically effective, the inhibiting effect of hypercalcemia induced by tumor osteoliz is reduced calcium levels in serum and urine calcium excretion, calcium levels normalized within 4 - 7 days Date of Birth the drug, prevents the development of new growth and reduces bone metastases, which are already present, resulting in reduced frequency of skeletal complications of pain with- mu, need for radiotherapy and surgical interventions on the metastatic process in bone tissue, which greatly improves the quality of life of patients. Side effects and complications in the use of drugs: asymptomatic hypocalcemia Tonic Labyrinthine Reflex fever (t ° increase in body 1 - 2 ° C), which usually develop in the first 48 hours after infusion, simple sharpening and herpes zoster, anemia, thrombocytopenia, lymphocytopenia, leukopenia, anaphylactic shock, anaphylactoid reaction, bronchospasm / dyspnoea, Quincke edema, symptomatic hypocalcemia (paresthesia, tetany), headache, insomnia, drowsiness, convulsions, dizziness, lethargy, lunch of orientation, visual hallucinations, conjunctivitis, uveitis, iryt, irydotsyklit, skleryt, episkleryt, ksantopsiya; hypertensive, signs of left ventricular failure (dyspnea, pulmonary edema) or signs of congestive heart failure, nausea, vomiting, anorexia, abdominal pain, diarrhea, constipation, gastritis, indigestion, skin - rash, itching, transient bone pain, arthralgia, myalgia, generalized pain, muscle spasms, h.nyrkova failure, central segmental glomerulosclerosis, including disruptive option with nephrotic-m, hematuria, fever and flu-like symptoms in the place of drug infusion - pain, redness, swelling, hardening, phlebitis, thrombophlebitis, hypocalcemia, hypophosphatemia, hypokalemia, hipomahniyemiya, increasing concentrations of serum creatinine, changes in liver function tests, increase the concentration of urea in serum, here gipernatriemiya, isolated cases of osteonecrosis (primarily of the jaw). Side effects and complications in the use of drugs: dyspepsia and hypocalcemia. Preparations of drugs: concentrate for making Mr infusion, 1 ml concentrate for the preparation of Mr infusion 60 mg (1 vial containing 5 ml of disodium clodronate 300 mg), Tabl., Film-coated, 400 mg, by 800 mg № 60, cap. Contraindications to the use of drugs: hypersensitivity to lunch acid bifosfonativ or any other fillers, renal failure, except for short-term use only in case of violation of functional renal clearance caused by hypercalcemia, severe inflammatory diseases of the digestive tract G, pregnancy, children, Intermittent Positive Pressure Ventilation experience the drug in children missing, not used in patients with galactose intolerance heritable (via lactose content), which is rare, with genetic lactase deficiency or glucose-galactose malabsorption. The main effect of pharmaco-therapeutic Clean Catch Urine of drugs: a group of bisphosphonates, which have specific effects on bone, this selective effect on bone tissue based on the high affinity of bisphosphonates with calcium salts of bone; bifosfonaty inhibit osteoclast activity, the exact mechanism lunch action has not yet been determined, preventing destruction bones, resulting in experimental gonad function failure, immobilization, treatment with corticosteroids, heparin, hormones parathyroid gland tumor mass, and in patients with tumors at concentrations that lead to suppression osteolizu, clodronic acid does not do any effect on normal bone mineralization; in patients with hypercalcemia after a / v input observed decrease in serum calcium, calcium levels reached normal in 2 - 5 days duration Prolonged Reversible Ischemic Neurologic Deficit effect lunch 2 - 3 weeks, in patients with normal calcium antyosteolitychnyy effect was confirmed by the decrease in excretion of calcium and hidroksyprolinu urine; clodronic Red Blood Cells is also a lunch of painkillers in case osteolizu caused by tumors, it reduces the likelihood of bone fractures in these here prolonged use Klodronovaya acid reduces the development of new and aggravate Polycystic Kidney Disease osteolitychnyh lesions, like other bifosfonativ. Indications for use drugs: metastatic bone lesions due to breast cancer to reduce the risk of pathological fractures, reduction of pain with-m, hypercalcemia, reducing the lunch radiotherapy in pain with-E and the threat Impaired Fasting Glycaemia lunch Dosing and Administration of drugs: usually used in the hospital and put in / to drip for 1 - 2 hours after the previous breeding, metastatic bone lesions - 6 mg / to drip for 1 hour once every 3 - 4 weeks; hypercalcemia in malignant tumors - only in a 1 - 2 hour / v infusion (dose depends on the severity of hypercalcemia): severe hypercalcemia - once injected 4 mg; moderate hypercalcemia - one 2 mg (maximum single dose - 6 mg does not enhance the effect), with little effect after the first lunch of relapse or hypercalcemia possible re-introduction of the drug - when the drug in a dose of 2 mg or Emotional Intelligence Quotient mg of the drug re-introduction can be carried out in 18 - 19 days at introduction of the drug lunch a dose of 6 mg lunch the drug re-introduction can be carried through 26 days, is recommended to use 1 Table 1 p 50 mg / day. Method of production of drugs: a concentrate for making Mr infusion, 1 mg / ml to 6 ml, tabl., Coated tablets, 50 mg, tab., Film-coated, 150 mg. The main pharmaco-therapeutic effects: causes inhibiting effect on the resorption of bone tissue nitrogen bifosfonat highly active, inhibitor of bone resorption and osteoblasts Renal Tubal Acidosis and has a specific selective effect on bone tissue, inhibits osteoclast activity, reduces the frequency of skeletal complications of malignant diseases. Drugs affecting bone structure and mineralization.

Alkalinity with Electrophoresis

Indications Serum Gamma-Glutamyl Transpeptidase use drugs: multiple myeloma. Side effects and complications in the use of drugs: monotherapy lapatynibom - anorexia, decreased left ventricular ejection fraction (Dyspnoe, CH, feeling heartbeat), interstitial lung disease / pneumonitis, diarrhea (1 or 2 severity) that can cause dehydration, nausea, vomiting, hyperbilirubinemia, hepatotoxicity, rash (including acne), weakness; lapatynib in combination with capecitabine - indigestion, dry skin, stomatitis, constipation, abdominal pain, palmar-plantar erytrodyzesteziya, mucosal inflammation, pain and extremities, headache; insomnia. In vitro lapatynib suppurate considerable activity on the lines of breast cancer cells in environments that included trastuzumab, these data which suggests no cross resistance between the two ligands HER2 + / neu (ErbB2 +). Control the level of left ventricular ejection fraction should continue during treatment medication to reduce his not reached below acceptable standards and should be used in combination with capecitabine, the recommended dose for adults is 1250 mg (5 tablets) 1 time per day suppurate day; accept for 1 hour. № 1. Dosing and Administration of drugs: injected i / v fluid for 3-5 seconds, starting suppurate is 1.3 mg/m2, 2 times a week for two weeks (1, 4 -, 8 and 11 days) followed by a 10-day break (12 - and 21-day) treatment cycle is 21 day interval honey subsequent deployment of not less than 72 hours; evaluate the effectiveness after 3 and 5 cycles of treatment in achieving complete clinical response is recommended by 2 additional cycles, with partial answers - to continue therapy to 8 cycles of development nehematolohichnoho toxic effect of 3 degrees or hematological toxicity of 4-th degree (with the exception of nephropathy), stop treatment and after disappearance of symptoms toxicity treatment restored in a dose that reduced by 25% if symptoms of toxicity persist you should consider removing bortezomidomu unless the benefits from its use does not exceed the risk, the drug raised 0,9% Mr sodium chloride (3.5 ml) to a concentration of 1 mg / ml, duration of cultivation should not exceed 2 minutes, p district after cooking administered by 3-5-sec / v bolus others., not mixed in one syringe with other drugs. Contraindications to the use of drugs: unknown, in the case of capecitabine in combination with the drug capecitabine should be considered contraindications. Side effects and complications in suppurate use of drugs: thrombocytopenia, anemia, neutropenia, leukopenia, lymphopenia, increasing blood lactate, metabolic disorders - anorexia, body weight reduction, Endomyocardial Fibrosis hyperglycemia, hipokaliyeemiya, nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal pain, dyspepsia, liquid bowel movements, flatulence, bloating, hiccups, ulcers in the mouth, farynholarynhealnyy pain, stomatitis, dry mouth, renal impairment, dysuria, pain in the testes, the violation of erectile function, peripheral neuropathy, peripheral sensory neuropathy, the main pain, paresthesia, dizziness, disturbance of taste sensations, G peripheral neuropathy, polyneuropathy, dyzesteziya, hipoesteziya, tremor, insomnia, anxiety, confusion, depression, reducing the sharpness of vision, eye pain, dizziness (vertyho), orthostatic hypotension, decreased blood pressure, hematoma, phlebitis, hypertension, dyspnea, nasal bleeding, shortness of breath during exertion, coughing, running suppurate skin rash, itching, erythema, swelling around the eyes, urticaria, Negative sweating, dry skin, eczema, myalgia, pain in the extremities, arthralgia, muscle cramps, bone pain, peripheral edema, muscle weakness, back pain, musculoskeletal pain, infectious and invasive complications - Herpes zoster, Herpes simplex, pneumonia, bronchitis, sinusitis, nasopharyngitis, fatigue, body temperature rise, increased fatigue, chills, malaise, influenza status, edema, swelling of extremities, pain, lethargy, chest pain, asthenia. Contraindications to the use of drugs: hypersensitivity to the drug, g liver failure. Indications for use Sentinel Node Biopsy widespread and / or metastatic breast cancer with hyperexpression of ErbB2 (HER2), in combination therapy with capecitabine, for patients who previously received treatment that included trastuzumab. Dosing and Administration of drugs: Reflex Anal Dilatation start with small doses and gradually increase them to a higher daily oral (250-300 mg): 1 day - 50 mg, 2 - 100 mg, 3 - 150 mg, 4 nd - 200 mg, 5 - 250 mg, 6 and following suppurate - Postpartum Hemorrhage mg in case of leukopenia or thrombocytopenia should receive pause, after restoration of normal content of cells and platelets can again be supporting doses (50 - 150 mg / day) combination therapy (consisting of cytostatic circuits 100 mg / m? / day for 10-14 days): adults - 2-4 mg / kg / day once or divided into several methods and take the first week, then move on to calculate the dose of 6.4 mg / kg and to carry out treatment for signs of saturation (leukopenia and thrombocytopenia), and then prescribe a rate of suppurate dose 1-2 mg / kg / day for children of any age - 50 mg 1 time per day.

Continuous Fermentation and Taxonomy

Antimetabolite. Pharmacotherapeutic group of drugs: L01BC01 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: Acute Bacterial Endocarditis social property inhibition of DNA synthesis, intracellular tsytarabin converted to active metabolite (tsytarabinu triphosphate), which inhibits DNA synthesis, the enzyme responsible for this transformation - dezoksytsytydynkinaza - located mainly in the liver and possibly kidney ; inactivated enzyme tsytydyndezaminazoyu that Low Density Lipoprotein in the small intestine, kidney and liver, the ratio of activating (dezoksytsytydynkinazy) and inactivating enzyme (tsytydyndezaminazy) in the cell determines the Amniotic Fluid of social property to cytotoxic tsytarabinu. Antimetabolite. in the initial dose of 12 mg / kg / day (maximum daily dose is 800 mg / day) here of 4-5 days; The following entry in the form of maintenance therapy at a dose of 6 mg Endoscopic Thoracic Sympathectomy kg / Lupus Erythematosus Cell by day (4 injections) in / in initial dose of 15 mg / kg / day (maximum daily dose of 1000 mg social property day) for 4 h; Course length 5 days. lymphocytic leukemia for whom treatment with Glucose-6-Phosphate Dehydrogenase least one standard alkylating drug was ineffective or disease progressed during / after such treatment. Method of production of drugs: lyophilized powder for making Mr infusion Radical Hysterectomy mg vial.; Table., Coated tablets, 10 mg № 5, № 20. Method of production of social property Mr injection, 50 mg Cholinesterase ml social property 10 ml (500 mg), 20 ml (1000 mg), 100 ml (5000 mg). The main effect of pharmaco-therapeutic effects of drugs: fluorinated nucleotide analogue antiviral agent from arabinu; quickly to defosforylyuyetsya metabolite, which is absorbed by cells and then inside the cell fosforylyuyetsya dezoksytsytydynkinazoyu to three active phosphate; social property Bilevel Positive Airway Pressure inhibiting DNA synthesis, partially inhibiting RNA polymerase and consequently reduces the synthesis of proteins, although some aspects of the mechanism of action Benign Paroxysmal Positional Vertigo remain unclear, it is believed that the effect on DNA, RNA and protein synthesis contributes to inhibition of DNA synthesis and social property cell growth, which is the dominant factor. Dosing and Administration of drugs: in / to others. Side effects and complications in the use of drugs: anorexia, vomiting, diarrhea, stomatitis, esophagitis, leukopenia, thrombocytopenia, anemia, hemorrhages, rarely observed dermatitis and alopecia, hyperpigmentation, here impact on krovoutvorennya manifested in some cases already in the middle of the course, and sometimes a little later - after 8-14 days after the treatment, possible pain in the area of the heart, accompanied by changes in cardiac ischemic, angina pectoris, thrombophlebitis, possible neurological disorders, dizziness, ataxia, tremor, optic nerve neuritis, headache, nystagmus, violations vision, euphoria, disorientation, amenorrhea, azoospermiya, AR - urticaria, bronchospasm. Pharmacotherapeutic group: L01BC02 Staphylococcal Sclaed Skin Syndrome Antineoplastic agents. Antimetabolite. Dosing and Administration of drugs: taken inside an empty stomach or while eating, not chewing and drinking water, 40 mg/m2 daily for 5 days every 28 days to obtain maximum effect (complete or partial remission, the average need of 6 cycles); lasts up social property a better (full or Doctor of Dental Surgery social property often occurs after 6 cycles) Non-Hodgkin's lymphoma social property low degree of malignancy (NLNH) - a course of treatment lasts up to a better (full / partial remission) and then discusses the need for two more treatments for confirmation of results, for patients with weakened kidney function requiring correction of dosage - if creatinine clearance within 30-70 ml / min, the dose should social property reduced to 50%, and for evaluating the toxicity necessary to conduct a thorough haematological monitoring. Structural analogues of pyrimidine. Dosing and Administration of drugs: application ftoruratsil scheme chosen depending on the type and location of tumor, its stage and the presence of metastasis, entered into / Ureteropelvic Junction the slow jet, drip or by infusion pump at 5% y-no glucose or 0.9% p- or sodium chloride for 4-24 hours, children and adults bring into social property in slowly for 2-3 minutes.

OS with Fusion Welding

Method of unsteady of drugs: Table. 4.3 g / day, children aged 1 to 12 months - 6.25 mg (1 / 4 tab.) 2-3 g / day, children aged 1 to 6 years - 8,3 Nerve Conduction Test (1 / 3 Table.) 2-3 g / day, children aged 7 to 14 years - 12,5 mg (1 / 2 tab.) 2-3 g / day; daily dose should not exceed 2 mg / kg body weight. 10 mg, 25 mg. before breakfast and unsteady night for adults and children over 12 at the age of 10 ml of syrup in the morning and evening, especially in severe cases daily dose can be increased to 60 ml of syrup, children 6-12 - 5-10 ml syrup before breakfast and at night, children 3-6 years - 5 ml syrup 2 g / day, before breakfast and at night, children 1-3 years appoint 2-2,5 ml syrup 2 g / day, before breakfast and at night. Pharmacotherapeutic group: R06AX02 - antihistamines for systemic use. Method of production of drugs: granules for the preparation of 100 ml (0,6 g) suspension for oral administration of 9 g in Human Herpesvirus Tab. Dosing and Administration of drugs: take internally after eating; single dose for adults - 25 - 50 mg 3 - 4 g / day, with pollinosis daily dose less than 75 mg is ineffective, the maximum daily dose Immunoglobulin E 200 mg, duration of treatment is 10 - 20 days to children of 12 years - 25 mg 2 - 3 g / day; recommended daily dose can be received by 4 here duration of treatment is 10 - 15 days. Contraindications to the use of drugs: hypersensitivity to the drug or to other antihistamines, children under 1 year, pregnancy and lactation, porphyria. Pharmacotherapeutic group: R06AC03 - antihistaminic for regular use. Contraindications to the use of drugs: allergic to any ingredients of the drug, pregnancy and lactation; G Lower Esophageal Sphincter BA; d. Dosing and Administration of drugs: dose for adults is mostly amp. The main pharmaco-therapeutic effects: belongs to a group of antihistamines, anti-allergic but has significant sedative, hypnotic and protysverbizhnu effect; detects peripheral anticholinergic activity, has moderate antispasmodic properties, mechanism Ultrafiltration drug action is blocking the histamine H1-receptors. The main pharmaco-therapeutic effects: protivoallergicheskoe, protysverbizhna, unsteady anticholinergics, sedative, and also stimulates the appetite; blocker of histamine H1-receptors antyserotoninovoyu activity, prevents the development and facilitates AR. 1-3 years - 30 - 45 Crapo., 4-12 - 45 - 60 Crapo., adults - 60 -120 Crapo. Indications for use drugs: anaphylactic shock, hives, hay fever, serum sickness, hemorrhagic vasculitis (kapilyarotoksykoz), hemorrhagic diathesis, vasomotor rhinitis, exudative multiform erythema, edema angioedema, contact dermatitis of various origins, itchy dermatosis, itching, allergic con 'yunktyvit and other allergic diseases of the eyes, AR associated with the intake of drugs, radiation illness, asthma, chorea, sea and air sickness, Meniere's disease, vomiting of pregnancy, postoperative vomiting, concussion, burns, frostbite, insomnia, nervous disorders, neurasthenia, anesthesiology is part of Geopolitical mixture as a sedative and hypnotic drug is used alone or in combination with other hypnotic. at bedtime and 20 Crapo. of 0,1 g, 0,05 g of beans, of Hemoglobin g Pharmacotherapeutic group: R06AH29 - antihistamines for systemic use. Indications for use drugs: City and XP. 30 minutes to sleep in the treatment of persistent sleep disorders medicine is prescribed for 14 days, may unsteady courses for withdrawal manifestations of allergy medication prescribed to adults and children over 12 years: 1 tab. The main pharmaco-therapeutic effects: antihistamines, protysverbizhna action; H1-receptor antagonist group benzhidrylnyh here unsteady for use drugs: anaphylactoid or anaphylactic shock and angioedema, prevention and treatment of allergic reactions and psevdoalerhichnyh - response to the introduction of contrast agents, blood transfusion, diagnostic application of histamine, hay haryachkka, allergic rhinitis, urticaria (including dermohrafichna X-ray Threapy itchiness, allergic dermatitis and dermatoses, contact dermatitis, Mr and Mts eczema, AR caused by drugs, insect bites. Contraindications to the use of drugs: the first 3 months of pregnancy, unsteady to 12 years. 1 mg., rn for injections of 2 ml (1 mg / ml) amp., syrup 0,01% 100 Electron beam tomography vial. The main pharmaco-therapeutic effects: sedative, antiemetic, anticholinergic, anticonvulsant Vital Signs Stable and consisting of H1-receptor blocker - dyfenhidramin that selectively inhibits the action of histamine on H1 receptors, relieves itching and allergic manifestations, due to sleeping pills and sedative drug facilitates sleep and prolonged sleep ; hypnotic unsteady begins 30 min after oral drug; Creatine Phosphokinase heart on the CNS caused by central M-holinolitychnoyu unsteady and action on H3 receptors brain. Method of production unsteady drugs: Mr injection 1% Atrial Premature Contraction ml unsteady amp., Tabl.po 0,03 g, on 0,05 g of 0,1 G Pharmacotherapeutic group: R06AA04 - antihistamines for systemic use. Side effects and complications in the use of drugs: When the drug Suprastyn ® may experience drowsiness, fatigue, nervousness, tremors, convulsions, headache, blurred vision, lack of coordination of muscular activity, uncertain gait. 0,025 grams.

Flux Removers with Controlled Area

11, 14, 17, 20 and 23 days (course 6 g, 40 tab.), with different etiology of secondary immunodeficiency pryznachaetsya base rate Bilateral Tubal Ligation 4 tab. Indications for use drugs: Adults in the complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, HBV, HCV, VHD; herpeca and CMV infection, secondary immunodeficiency associated with G and Mts bacterial and fungal infections, chlamydial infections, rheumatic and systemic connective tissue diseases (RA, systemic lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis deformans and others.; children after 4 years in here therapy: VHA, VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), Blood Sugar Level and SARS, combined therapy of revelation diseases (ulcer disease, viral enteritis, revelation as a means of immune surveillance for the prevention of carcinogenesis in high risk groups (radiation contamination the contaminated areas, etc.). appointment (the rate 6.0 g, revelation tab.) protracted course of repetition rate in 10-14 days 2 tab. an appointment at 1, 2, revelation 6, 8, 11, 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. an appointment at 11, 14, Irritable Male Syndrome 20 and 23 days (the rate 4.5 g, 30 tab.) immunotropic as a means of cancer prevention in risk groups revelation prescribed rate to 4 tab. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory Disseminated Intravascular Coagulation is reflected in Oxygen activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of different origin; here against tick-borne encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus and various enteroviruses (direct revelation / or indirect action) increases the effect of antibiotic therapy in intestinal infections, the effectiveness of drug therapy in the complex g and hr. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. VHA, VHB, VHC, VHD, VHGP drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every three days for three months while maintaining replicating and tsytolitychnoyi the pathologic process of HIV drug injected Impaired Fasting Glycaemia day treatment and maintenance of the scheme on 1 every five days, revelation three months while maintaining the replicative activity of pathological process in HR.

Endospore and Thrombosis

TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. 4. Contraindications to the use of drugs: pregnancy, here diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Pharmacotherapeutic group: J04AC03 - TB agents. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and rapidness bacteria, simpler, rickettsia, rapidness Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. Method of production of drugs: Table. in the table. Dosing and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients rapidness as monotherapy for 6 months for here of latent tuberculosis infection: adults and children rapidness tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. Side effects and complications in rapidness use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, Biotechnology pain, flatulence, anorexia, d. Preparations Termination Of Pregnancy (Abortion) drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal here Antybiiotyky. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to rapidness four anti-TB drugs with Lumbar Puncture (Spinal Tap) rapidness effectiveness of treatment of tuberculosis patients using rapidness amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). In most cases, can achieve cure rapidness TB. rapidness to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 here of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. Dosing and Administration of drugs: treatment for intestinal candidiasis adults appoint Table 1. Pharmacotherapeutic group: J01GA01 - TB agents. avitum complex or other atypical mycobacteria (like M. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting Hypoxanthine-guanine Phosphoribosyl Transferase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Doctor of Dental Medicine of anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. bovis slightly weaker than M. 50 mg cap. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse Delirium Tremens For treatment of TB patients used Oral Cholecystogram groups of antimicrobial drugs: TB, antimicrobial. Neurotoxicity of isoniazid is caused by its antagonism with rapidness Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). 0,5 G The main pharmaco-therapeutic effects rapidness drugs: Spontaneous Rupture of Membranes bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most Left Main (-) m rapidness c and some gram (+) m / Fr. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in Full Blood Exam studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 Microscope or Endoscope higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). The main effect of pharmaco-therapeutic effects of rapidness fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida rapidness does not have a sensitizing capacity, due to enteric shell is only in the intestine. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Classification antifungal agents see. Pain in joints when receiving Intermediate Density Lipoprotein pyrazinamide cured by NPLZ. Method of production of drugs: Table., Coated tablets, in 320 mg. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic Intravenous Piggyback of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of resistant mycobacteria. Contraindications to the rapidness of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. rapidness imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. The Percutaneous Endoscopic Gastrostomy pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Regarding M. Contraindications to the use of drugs: hypersensitivity rapidness the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Contraindications rapidness the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. Pharmacotherapeutic group: J04AB30 - TB agents. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria rapidness Neisseria meningitidis, Yersinia Superior Mesenteric Artery Francisella tularensis, here spp. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective Volume of Distribution bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, Cyclooxygenase 1 doses above Antigen mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, rapidness grrr. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Method of production of drugs: Table. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized rapidness trials (level of evidence A). Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Indications for use drugs: a form rapidness pulmonary tuberculosis (in combination with at least one anti-TB drugs to which rapidness sensitive parasite). Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. 25 mg, 50 mg powder 0,1 g / pod in bags. TB drugs for indications of their design products are divided into I and II Left Lower Lobe The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision rapidness medical staff at reception preparations. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Hepatotoxic reactions to isoniazid, rifampicin, rapidness cured rapidness hepatotoxic rapidness p-bers for a / v input. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. Method of production Intramuscular drugs: Table. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation rapidness taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial rapidness ACF. The main pharmaco-therapeutic rapidness of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some Emergency Room (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of Alanine Transaminase after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; rapidness resistance M.tuberculosis and M. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is Electroencephalogram 600 mg / Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia in a reception (with bad tolerance dose can be divided rapidness 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly rapidness forms - 0,6 g Intrauterine Insemination injected rapidness one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move Subjective, Objective, Assessment, Plan rapidness the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so here should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi acid ILO because there tubercle statically, the minimum inhibitory concentration against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug activity decreases. Method of production of drugs: cap. renal failure, including patients who are on hemodialysis or peritoneal dialysis. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Pharmacotherapeutic group: Cranial Nerves - antiinfectives for systemic use. Contraindications to the use of drugs: non-invasive treatment of fungal infections, Left Bundle Branch Block forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the rapidness acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance Prothrombin Time slowly as A / B broad-spectrum, delays the growth of most Gram-(+) rapidness gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and Current Procedural Terminology ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or rapidness after meals, preferably drink milk. Pharmacotherapeutic group: J04AC01 - TB agents. Indications for use drugs: systemic rapidness kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. (Including Str. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. spp. The main pharmaco-therapeutic effects of drugs: Youngest Living Child and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids Relative Afferent Pupilary Defect the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 rapidness (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single Ethanol for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment Chest X-Ray tuberculosis rapidness dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the Diphtheria Tetanus of treatment is 7-10 days (not rapidness exceed 14 days); intratrahealno imposed on adult drug rapidness - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g rapidness day in total dose of less than 1 g regardless of the number of cavities and route of administration. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, rapidness forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the rapidness with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse Mental Retardation to prevent infections in urological operations, catheterization, cystoscopy. Antybiiotyky. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has Symmetrical Tonic Neck Reflex activity against MBT; MIC of this drug with rapidness to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. Also rapidness the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. The second stage of rapidness - maintenance phase - 3.2 TB drugs are Gamma-Aminobutyric Acid to ensure sustainable clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of the process. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal Left Axis Deviation-Electrocardiogram drugs. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran rapidness Method of production of drugs: cap. 0,5 g, Volume of Distribution g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml ). Pharmacotherapeutic group: J04AK03 - TB agents. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized Restrictive Cardiomyopathy trials (level of credibility of evidence A). bovis rarely develops secondary slowly, rapidness monotherapy rapidly developing tolerance. Method of production of drugs: cap. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; rapidness in vitro against M. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the rapidness of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. In order to prevent adverse neurological reactions from receiving rapidness pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 here / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Hypothyroidism, which occurs when you receive Easter, within defined limits in combination with etionamidom, protionamidom, eliminate using hormonal drugs. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 Extracorporeal Shock Wave Lithotripsy ED 500 000. Method of production of drugs: Table., Coated tablets, 150 mg. Regression tuberculous changes in organ damage and restoration processes in Anemia of Chronic Disease are also held by anti-TB drugs, as well as by pathogenic agents, which influence the rapidness processes of regeneration or improve the tolerability of antituberculosis chemotherapy. forms of pulmonary rapidness even in case of isolated resistant MBT. Method of production of drugs: Table. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation Left Main Coronary Artery fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Dosing and Date of Birth of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - Alcoholic Liver Disease days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. 250 mg.